Inhibitor Therapeutics, Inc.
INTI· OTC
INTIInhibitor Therapeutics, Inc.
Filed Aug 13, 2014 · 10-Q · 44 days after period end · 0001193125-14-308476
| Metric | Q2 2014 | Q2 2013 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$2.14M | -$266.90K |
| EPS Diluted | -$0.10 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inhibitor Therapeutics, Inc. · CIK 1042418 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 13, 2014 · 44 d after period end
